The 4th Asia Healthcare Summit, co-organized by the HKSAR Government and the Hong Kong Trade Development Council, was held at the Hong Kong Convention and Exhibition Centre from 16 May to 17 May. The Chief Executive of the HKSAR, Mr. K.C. Lee, and the Deputy Director of the National Health Commission, Mr. Cao Xuetao, attended the opening ceremony and delivered speeches, while the Director-General of the World Health Organization, Mr. Tamsin Tandesay, delivered a video message. Zhou Houcheng, Chairman of the Board of Directors of Sichuan Neo-Green Pharmaceutical Technology Development Co., Ltd (hereinafter referred to as NGP), was invited to participate in the event, and New Green Pharmaceutical made a stunning appearance with its modernized products of Chinese medicine, such as Chinese medicine granules, Chinese medicine health series products and Chinese medicine granules intelligent mixing equipment.
At the exhibition, leaders such as Cao Xuetao, Deputy Director of the National Health and Wellness Commission, Tian Xingjun, Secretary of the Party Group and Director General of the Sichuan Provincial Bureau of Traditional Chinese Medicine, Lo Koumou, Director of the Hong Kong Medical and Health Bureau, and Fong Shun-man, President of the Hong Kong Trade Development Council, visited the booth of the New Green Pharmaceuticals and gained an in-depth understanding of the products of the New Green Pharmaceuticals. The Chinese medicine granules, which are convenient to carry and do not need to be decocted, and the Smart TCM Pharmacy, which has high dispensing efficiency and digitalized management, were highly praised and recognized by the leaders and experts on site.
With the theme of Innovation and Integration, the forum brought together nearly 3,000 health industry elites from 40 countries and regions around the world to discuss in-depth the challenges and opportunities of the global healthcare industry, the latest development of medical technology and the potential of the Asian healthcare market.
In the panel discussion on “Application of Chinese Medicine in Modern Healthcare”, Prof. Bian Siu-cheung, Hospital Chief Executive of Hong Kong Chinese Medicine Hospital (HKCMH) and President of the Chinese Medicine Innovation R&D Center Limited, Prof. Fung Yick-pan, Dean of the Faculty of Chinese Medicine of The University of Hong Kong, Prof. Lau Chun-ying, Deputy Hospital Chief Executive (Western Medicine) of HKCMH, Prof. Xu Hong-xi, Chief Professor of the University of Traditional Chinese Medicine, Honorary Dean of the School of Chinese Medicine, and other distinguished speakers were invited to attend. Prof. Xu Hongxi, Chief Professor of Shanghai University of Traditional Chinese Medicine and Honorary Dean of the School of Traditional Chinese Medicine, and other industry leaders gathered together. Mr. Xu Liming, General Manager of New Green Pharmaceutical, was also invited to attend the meeting to discuss with industry experts about the modernization and future development trend of TCM in Hong Kong, and to share New Green Pharmaceutical's experience in quality control through the whole industry chain system and modern analytical technology, so as to contribute to the promotion of the modernization and internationalization of TCM.
Make good use of Hong Kong's internationalization advantages and explore the path of enterprise globalization. The invitation to participate in the Hong Kong Asia Healthcare Forum not only effectively enhanced NGP's visibility and influence in Hong Kong, but also injected new vitality into the globalization development of New Green Pharmaceuticals. In the future, NGP will continue to adhere to scientific and technological innovation, actively respond to the national “going out” development strategy, and continuously promote brand globalization, help Chinese medicine to the world, and contribute to the health of all mankind.
